Remove 2016 Remove Leads Remove Networking
article thumbnail

EMA issues guidance amidst European medicine shortage

Pharmaceutical Technology

The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain. Shortages can lead to medicine rationing and delay in critical treatments, with a significant impact on patient care.

article thumbnail

HeartBeam Announces Acquisition of LIVMOR Assets

Legacy MEDSearch

Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. Initiatives in the UK such as the Clinical Practice Research Datalink (CPRD), The Health Improvement Network (THIN) and OpenSAFELY support UK, European, and international studies. Meta-analyses contributed least frequently (31.4 2018; 8(1).

Medicine 116
article thumbnail

B2B Sales Prospecting: What You Need To Know

Spotio

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

article thumbnail

Neglected tropical diseases: non-profits lead the way as private sectors lags

Pharmaceutical Technology

In Germany, pharma companies like Bayer and Merck KGaA are members of the German Network against Neglected Tropical Diseases. Acoziborole was previously discovered by the company Anacor Pharmaceuticals, which Pfizer acquired in 2016. For example, Merck & Co.

Leads 64
article thumbnail

NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64

Legacy MEDSearch

Trauma/ER: The BodyTom 64’s unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite. The BodyTom 64 brings the power of innovative imaging to patients’ bedsides safely and efficiently. About NeuroLogica. NeuroLogica Corp.,

FDA 92
article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

Between May 1, 2016, and May 31, 2021, 42% of all U.S. When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy. Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016–2021.” JAMA Network Open 5 , no. References: 1. Lythgoe, and Vinay Prasad.